Zonation of labeling of lipogenic acetyl-CoA across the liver: implications for studies of lipogenesis by mass isotopomer analysis.
Measurement of fractional lipogenesis by condensation polymerization methods assumes constant enrichment of lipogenic acetyl-CoA in all hepatocytes. mass isotopomer distribution analysis (MIDA) and isotopomer spectral analysis (ISA) represent such methods and are based on the combinatorial analyses of mass isotopomer distributions (MIDs) of fatty acids and sterols. We previously showed that the concentration and enrichment of [13C]acetate decrease markedly across the dog liver because of the simultaneous uptake and production of acetate. To test for zonation of the enrichment of lipogenic acetyl-CoA, conscious dogs, prefitted with transhepatic catheters, were infused with glucose and [1,2-13C2]acetate in a branch of the portal vein. Analyses of MIDs of fatty acids and sterols isolated from liver, bile, and plasma very low density lipoprotein by a variant of ISA designed to detect gradients in precursor enrichment revealed marked zonation of enrichment of lipogenic acetyl-CoA. As control experiments where no zonation of acetyl-CoA enrichment would be expected, isolated rat livers were perfused with 10 mm [1,2-13C2]acetate. The ISA analyses of MIDs of fatty acids and sterols from liver and bile still revealed a zonation of acetyl-CoA enrichment. We conclude that zonation of hepatic acetyl-CoA enrichment occurs under a variety of animal models and physiological conditions. Failure to consider gradients of precursor enrichment can lead to underestimations of fractional lipogenesis calculated from the mass isotopomer distributions. The degree of such underestimation was modeled in vitro, and the data are reported in the companion paper (Bederman, I. R., Kasumov, T., Reszko, A. E., David, F., Brunengraber, H., and Kelleher, J. K. (2004) J. Biol. Chem. 279, 43217-43226).
Department of Nutrition, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Ilya R
IR
Bederman
Aneta E
AE
Reszko
Takhar
T
Kasumov
France
F
David
David H
DH
Wasserman
Joanne K
JK
Kelleher
Henri
H
Brunengraber
D000085:Acetates / Q000378:metabolism; D000105:Acetyl Coenzyme A / Q000737:chemistry*; D000818:Animals; D001646:Bile / Q000378:metabolism; D002404:Catheterization; D002784:Cholesterol / Q000378:metabolism; D004285:Dogs; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D005947:Glucose / Q000378:metabolism; D022781:Hepatocytes / Q000378:metabolism; D008055:Lipids / Q000737:chemistry*; D008079:Lipoproteins, VLDL / Q000737:chemistry; D008099:Liver / Q000378:metabolism*; D008110:Liver Extracts; D008297:Male; D008956:Models, Chemical; D008962:Models, Theoretical; D010477:Perfusion; D011169:Portal Vein / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013261:Sterols / Q000378:metabolism; D013997:Time Factors; D014465:Ultrasonics
D000085:Acetates; D005227:Fatty Acids; D008055:Lipids; D008079:Lipoproteins, VLDL; D008110:Liver Extracts; D013261:Sterols; D000105:Acetyl Coenzyme A; D002784:Cholesterol; D005947:Glucose